ArticleBioPsychoSocial medicine2026
Usability study to guide the development of a cognitive behavioral therapy mobile application for reducing irritable bowel syndrome symptoms.
Article in BioPsychoSocial medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIrritable bowel syndrome (IBS) is a prevalent disorder of gut-brain interaction in which psychosocial factors can exacerbate symptoms. Although cognitive behavioral therapy (CBT) has proven effective in alleviating IBS symptoms, its widespread implementation is limited by therapist shortages and the substantial time demands placed on both patients and clinicians. Mobile health–delivered Just-in-Time Adaptive Interventions (JITAIs) may overcome these barriers by providing continuous, personalized support. In this study, we simulated the core functions of a JITAI-based CBT application via Google Forms and gathered feedback from patients and clinicians for application development.
methodsIn this three-month, multicenter observational study, ten adults meeting Rome IV criteria for IBS were enrolled from three psychosomatic clinics in Japan. Using Google Forms as a prototype, we delivered: a daily symptom diary, an exposure-therapy module with anxiety-hierarchy support and automated progression prompts, and an educational website. Usage data were recorded automatically, and feasibility, burden and satisfaction were assessed through post-study questionnaires with patients (n = 8) and semi-structured interviews with patients (n = 3) and physicians (n = 4).
resultsAll ten participants (three women; mean age 28.4 years, range 18–52) completed the study (IBS with diarrhea [IBS-D] n = 6; IBS with constipation and diarrhea [IBS-M] n = 3; IBS unclassified [IBS-U] n = 1). Mean daily symptom diary completion rate was 94.9% (range 79.4–100%). A mean of 17.2 exposure sessions was recorded (range 2–53). In the usability questionnaire (n = 8/10), 6/8 (75%) agreed/strongly agreed that they wanted to continue the daily symptom diary, and 5/8 (62.5%) agreed/strongly agreed that they would recommend the prototype to others with IBS symptoms. The educational website was infrequently accessed. In patient interviews (n = 3), two participants who repeatedly practiced exposure reported perceiving declines in their Subjective Units of Distress over time, which encouraged continued practice. Interviews with physicians highlighted the need for an integrated mobile-application interface offering real-time visual feedback and streamlined hierarchy creation.
conclusionsHigh completion rates showed that smartphone self-tracking and exposure exercises were acceptable to patients with IBS. The future application should automate hierarchy building, embed educational content, and include participants with a broader range of IBS subtypes. Developing a dedicated JITAI application and conducting larger, controlled trials are needed to confirm clinical efficacy and long-term adherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.